Research News

Researchers from the GW Cancer Center published in JAMA Dermatology on the efficacy of preventative strategies for adverse effects of taxane-based chemotherapy.

The study published in the Journal of Neuroscience suggests the thalamus controls the development of state dependency and continuity.

GW and the FDA published an update to the BioCompute Object Specification Project, which provides much-needed standards for communicating high-throughput sequencing computations and data analysis, known as BioCompute Objects.

The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the GW School of Medicine and Health Sciences. 

The GW Postdoc Association hosted Postdoc Appreciation Day on Sept. 21 as part of the National Postdoc Association Postdoc Appreciation Week from Sept. 17–21. 

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.

Paul Brindley, PhD, has received more than $1.7 million from the National Cancer Institute at the National Institutes of Health to investigate the cellular and molecular links between liver fluke infection and bile duct cancer.

The GW School of Medicine and Health Sciences is one of 12 top medical research centers to collaborate with the Scleroderma Research Foundation to launch CONQUER: the first-ever national, longitudinal patient registry for those suffering from scleroderma.